Read your latest personalised notifications
Sign in
No account yet? Start here
Don't miss out
Ok, got it
Join Prof. Burkert Pieske, Prof. Rudolf de Boer and Prof. Andrew Coats
Free for everyone
Learning objectives
This Webinar addresses a major unmet clinical need: the patient with suspected HFpEF, the pathophysiology, diagnostic approaches, and current management strategies.
Expected outcomes:
You must be registered and identified by login via the link below or sent to you by email in order to view the live event.
I have already registered and want to access the live event.
Register now
How to access the live event
Upon registration, you will receive a confirmation email with the connection details. Please check your spam if you do not receive any email or contact us.
You need a valid MY ESC login and password to register and to access the live event. Retrieve your password or create your MY ESC account.
Professor Rudolf de Boer, FESC, FHFAUniversity Medical CentreGroningen, Netherlands
Professor Burkert Pieske, FESC, FHFACharite Medical UniversityBerlin, Germany
Professor Andrew Coats, FESC, FHFAUniversity of Warwick Coventry, United Kingdom
This webinar addresses general cardiologists but also cardiologists wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).
This educational programme is accredited for 1 CME Credit(s). Each participant should claim only those hours of credits that have actually been spent in the educational activity.
Find out more about CME and accreditation.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
Tel. +33.4.92.94.76.00
Fax +33.4.92.94.76.01
This programme is supported by Novartis in the form of an educational grant.
The scientific programme has not been influenced in any way by its sponsor.
Our mission: To reduce the burden of cardiovascular disease